The estimated Net Worth of Jeffrey Moy is at least $30.9 Million dollars as of 11 March 2020. Mr. Moy owns over 6,203 units of Dexcom Inc stock worth over $2,149,753 and over the last 16 years he sold DXCM stock worth over $28,786,874. In addition, he makes $0 as Senior Vice President - Operations at Dexcom Inc.
Jeffrey has made over 44 trades of the Dexcom Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 6,203 units of DXCM stock worth $1,642,306 on 11 March 2020.
The largest trade he's ever made was selling 59,193 units of Dexcom Inc stock on 28 June 2018 worth over $5,474,169. On average, Jeffrey trades about 5,646 units every 36 days since 2008. As of 11 March 2020 he still owns at least 31,397 units of Dexcom Inc stock.
You can see the complete history of Mr. Moy stock trades at the bottom of the page.
Jeffrey C. Moy serves as Senior Vice President - Operations of the Company. He has served as our Senior Vice President of Operations since January 2011 and was promoted to Executive Vice President, Operations, effective October 1, 2019. He previously served as our Vice President of Operations from September 2008 to January 2011. Previously, Mr. Moy served as our Senior Director of Manufacturing from September 2007 to September 2008. From April 2004 to August 2007, Mr. Moy served as Senior Director of Manufacturing for Biosite, Inc., a manufacturer of diagnostic products for point of care medicine. Mr. Moy received a B.S. from the University of Pennsylvania and a Masters in Engineering from Cornell University.
Jeffrey Moy is 59, he's been the Senior Vice President - Operations of Dexcom Inc since 2011. There are 11 older and 17 younger executives at Dexcom Inc. The oldest executive at Dexcom Inc is Andrew K. Balo, 73, who is the Exec. VP of Regulatory Strategy, Clinical Affairs & Strategic Partnership Devel..
Jeffrey's mailing address filed with the SEC is 6340, Sequence Drive, Sorrento Valley, San Diego, San Diego County, California, 92121, United States.
Over the last 20 years, insiders at Dexcom Inc have traded over $724,717,982 worth of Dexcom Inc stock and bought 165,450 units worth $3,489,100 . The most active insiders traders include Sean Carney, Kim D Blickenstaff, and Steven R Altman. On average, Dexcom Inc executives and independent directors trade stock every 7 days with the average trade being worth of $892,438. The most recent stock trade was executed by Sadie Stern on 9 September 2024, trading 426 units of DXCM stock currently worth $29,458.
founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
Dexcom Inc executives and other stock owners filed with the SEC include: